Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Mar 24 | RVNC Revance Therapeutics | Common Stock | Sell | Dispose S | No | No | 5.0425 | 9,211 | 46.45 k | 167,550 |
15 Mar 24 | RVNC Revance Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 5.305 | 2,967 | 15.74 k | 176,761 |
29 Feb 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 22,110 | 0.00 | 179,728 |
31 Dec 23 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 7.47 | 264 | 1.97 k | 157,618 |
15 Dec 23 | RVNC Revance Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 8.08 | 4,712 | 38.07 k | 157,354 |
11 Aug 23 | RVNC Revance Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 18.91 | 8,901 | 168.32 k | 162,066 |
11 Aug 23 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 22,620 | 0.00 | 170,967 |